Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Prospective, Multicenter, Controlled Trial Evaluating the Implant of a Drug Eluting Stent (XIENCE PRIME, Abbott Vascular) in the Critically Ischemic Lower Leg

NCT01442636 is registered in ClinicalTrials.gov with Flanders Medical Research Program as lead sponsor.

NCT NCT01442636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01442636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Prospective, Multicenter, Controlled Trial Evaluating the Implant of a Drug Eluting Stent (XIENCE PRIME, Abbott Vascular) in the Critically Ischemic Lower Leg
Lead sponsor
Flanders Medical Research Program
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2011
Completion date
November 30, 2014
Enrollment
60 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease